Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 120.16M P/E - EPS this Y -20.10% Ern Qtrly Grth -
Income -178.51M Forward P/E -0.64 EPS next Y 19.70% 50D Avg Chg -26.00%
Sales 122.57M PEG -0.13 EPS past 5Y - 200D Avg Chg -51.00%
Dividend N/A Price/Book 3.20 EPS next 5Y 15.80% 52W High Chg -86.00%
Recommedations 2.00 Quick Ratio 4.24 Shares Outstanding 80.64M 52W Low Chg 22.00%
Insider Own 35.28% ROA -17.43% Shares Float 53.18M Beta 1.58
Inst Own 43.54% ROE -705.53% Shares Shorted/Prior 2.93M/3.72M Price 1.49
Gross Margin -9.08% Profit Margin -145.64% Avg. Volume 519,106 Target Price 8.75
Oper. Margin -258.08% Earnings Date Feb 26 Volume 339,555 Change -1.32%
About ADC Therapeutics SA

ADC Therapeutics SA, a commercial-stage biotechnology company, develops antibody drug conjugates (ADC) for patients suffering from hematological malignancies and solid tumors. Its flagship product ZYNLONTA that is in Phase II clinical trial for the treatment of relapsed or refractory diffuse large B-cell lymphoma (DLBCL) and follicular lymphoma; and LOTIS-7, a Phase Ib clinical trial for treatment of relapsed or refractory B-cell lineage non-hodgkin lymphoma (B-NHL). The company is also developing camidanlumab tesirine, an ADC composed of a monoclonal antibody that binds to CD25 conjugated to a PBD–dimer toxin, as well as in Phase II clinical trial in relapsed or refractory hodgkin lymphoma. In addition, it develops ADCT-602, which is in Phase I/II clinical trial for treatment of acute lymphoblastic leukemia; ADCT-601 that are in Phase Ia clinical trial for treatment of various solid tumors and hematological malignancies; and ADCT-212, a second-generation PBD-based ADC targeting prostate-specific membrane antigen (PSMA), including ADCT-701 and ADCT-901 for the treatment of solid tumors. It has a collaboration and license agreement with Genmab A/S, Bergenbio AS, Synaffix B.V., Mitsubishi Tanabe Pharma Corporation, Overland Pharmaceuticals, and MedImmune Limited. ADC Therapeutics SA was incorporated in 2011 and is headquartered in Epalinges, Switzerland.

ADC Therapeutics SA News
02/21/24 Earnings Preview: Cytek Biosciences, Inc. (CTKB) Q4 Earnings Expected to Decline
02/20/24 Earnings Preview: ADC Therapeutics SA (ADCT) Q4 Earnings Expected to Decline
02/16/24 15 Top Performing European Stocks So Far in 2024
02/15/24 The 3 Biotech Stocks That Could Make Your February Unforgettable
02/13/24 Biogen Inc. (BIIB) Lags Q4 Earnings and Revenue Estimates
02/08/24 The 3 Most Undervalued Biotech Stocks to Buy in February 2024
01/19/24 ADC Therapeutics (ADCT) Rises 43% in a Month: Here's Why
01/19/24 Is ADC Therapeutics (ADCT) Outperforming Other Medical Stocks This Year?
01/04/24 ADC Therapeutics Regains Compliance with NYSE Continued Listing Standards
01/04/24 ADC Therapeutics Provides Business Updates
12/15/23 ADC Therapeutics SA (NYSE:ADCT) institutional owners may be pleased with recent gains after 46% loss over the past year
12/12/23 ADC Therapeutics Announces Initial Results from Investigator-Initiated Phase 2 Clinical Trial Evaluating ZYNLONTA® in Combination with Rituximab in Patients with Relapsed/Refractory Follicular Lymphoma (FL)
11/20/23 Sobi to present new data at ASH 2023 Annual Meeting
11/15/23 Myricx Bio Appoints Dr Chris Martin, Biotech Entrepreneur and ADC Pioneer, as Chairman of its Board of Directors
11/08/23 ADC Therapeutics SA (NYSE:ADCT) Q3 2023 Earnings Call Transcript
11/08/23 Q3 2023 ADC Therapeutics SA Earnings Call
11/07/23 ADC Therapeutics SA (ADCT) Reports Q3 Loss, Lags Revenue Estimates
11/07/23 ADC Therapeutics Receives NYSE Notice of Non-Compliance With Continued Listing Standards
11/07/23 ADC Therapeutics Reports Third Quarter 2023 Financial Results and Provides Business Updates
11/06/23 ADC Therapeutics to Participate in the Jefferies London Healthcare Conference
ADCT Chatroom

User Image ViractaTrader77 Posted - 1 day ago


User Image ViractaTrader77 Posted - 1 day ago

$VINC From listening to this interview with Ahmed Hamdy does make it sound like VIP943 for AML is working very well in dose escalation Phase 1. He said they are VERY VERY happy with it. Plus data is due out on the enhertu like small molecule drug conjugate in March (The warhead is a CPT payload on steroids like Enhertu). So this is a major opportunity. So, considering they have a cell trapper moiety for warheads. We could see this go to a Billion dollar market cap. Expecting a partnering deal considering they have skipped on raising money. He sold Acerta for $7 billion. Stock ripped past week. 2,000,000 shares popped stock up to $4.14. However, only 670,000 paired back and took profits yesterday. Therefore 67% of investors are holding hopefully long term. Which spells good things considering the ADC field is booming. $IMNM $AMAM $ADCT $PYXS https://www.youtube.com/watch?v=5M9Yhxe4BeA

User Image Pharmer23 Posted - 2 days ago

$ADCT we ve seen this many times before . It takes a breather , consolidates and blast off . Best pick of my short trading life. Turned 15 k to over 100 k .. it’s not done

User Image RigidFlexibility Posted - 2 days ago

$ADCT …just curious, anyone know if there’s a way to view a chart that shows the history of the number of Watchers for a ticker on ST?

User Image Benasis Posted - 2 days ago

$ADCT super bullish on her, I still believe this is an early buy point, but that’s just me

User Image lob11 Posted - 2 days ago

$ADCT been long since 90 cents didn't quite load the boat. Wish I had.

User Image RigidFlexibility Posted - 4 days ago

$ADCT …let’s go back to that 5.93 level. Maybe they were robbing stop losses, or it was just purely market conditions. No matter, I’m hanging in there. Long and..

User Image _www_larval_com_ Posted - 4 days ago

$ADCT just dropped -8% lower to -5% (~210Kv) a few minutes ago, 03/15 options, follow for more volatility.

User Image Tucumcari Posted - 4 days ago

$ADCT $4.60

User Image GreenField2021 Posted - 4 days ago


User Image Benasis Posted - 4 days ago


User Image BobBuran Posted - 4 days ago

Wednesday Dow opens -26 and we open deep red with $ADCT #stocks

User Image GreenField2021 Posted - 5 days ago

$ADCT still true :-)

User Image popculture Posted - 5 days ago

$ADCT who’s still holding ?

User Image buy_undervalued_stocks Posted - 5 days ago

$ADCT nice, nearly a 20% move in 5 hours? Shouldn't be remotely possible. Only at the casino...

User Image josegodoy Posted - 5 days ago

$ADCT Watching this one

User Image RigidFlexibility Posted - 5 days ago

$ADCT …just a blip…nothing to see here. Continue the elevator ride to Pluto. Lol. GLTA

User Image BobBuran Posted - 5 days ago

Tuesday With Dow closing -64 we close with small negative. Best: $MINM Worst: $ADCT #stocks

User Image _www_larval_com_ Posted - 5 days ago

$ADCT has dropped -3% lower to -9% (~2Mv) moments ago, 03/15 options, follow for more volatility.

User Image essiepaul Posted - 5 days ago

$ADCT another wainwright sheet show

User Image Tucumcari Posted - 5 days ago

$ADCT it’s been trading above safe level at $3.80. Watch if this holds $4.60 or it will go back well below safe level real quick.

User Image ViractaTrader77 Posted - 5 days ago

$VINC ADC platform Vincerx... New Video https://www.youtube.com/watch?app=desktop&v=5M9Yhxe4BeA $IMNM $AMAM $CRBP $ADCT

User Image NobVega Posted - 5 days ago

$LUNR In at $10.38. Everybody on the planet is going to hear about this if they land on the moon Thursday. Also holding $ADCT $ARQT $XERS $TGB. All winners.

User Image AboutAWe3kAgo Posted - 5 days ago

$ADCT Turned $280 to $6000. This stock is most likely going to keep running. I might regret it later but I am out for now.

User Image RallyRaider Posted - 5 days ago

$ADCT no offering points to better things ahead. mid dec was telling!

User Image farcanal Posted - 5 days ago

$ADCT well, the restoration of sanity has certainly been lucrative 🥳

User Image NobVega Posted - 5 days ago

$ADCT Quickly going to $9 target just like $ARQT did. Sweet gift this morning.

User Image Joneymoney Posted - 5 days ago

Real-Time Stock Data $ADCT Price: 5.69 Volume: 424001 Market Cap: 460452512 PE Ratio: -2.973854 All data provided by: Artificial Intelligence Tech Solutns Inc (AITX)

User Image GreenField2021 Posted - 5 days ago

$ADCT just unbelievable

Analyst Ratings
HC Wainwright & Co. Buy Feb 20, 24
HC Wainwright & Co. Buy Nov 20, 23
TD Cowen Market Perform Nov 9, 23
RBC Capital Outperform Nov 8, 23
HC Wainwright & Co. Buy Sep 19, 23
RBC Capital Outperform Sep 12, 23
JP Morgan Neutral Aug 10, 23
RBC Capital Outperform Aug 9, 23
HC Wainwright & Co. Buy Jul 25, 23